Barinthus Biotherapeutics (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

0.93

-0.16 (-14.68%)

At close: May 02, 2025, 3:59 PM

0.95

2.27%

After-hours: May 02, 2025, 04:05 PM EDT

Barinthus Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-61.18M	-73.63M	5.32M	-51.11M	-17.93M	-20.82M
Depreciation & Amortization	5.8M	n/a	4.32M	602K	208K	346.86K
Stock-Based Compensation	4.71M	5.05M	9.88M	16.49M	3.63M	n/a
Other Working Capital	1.7M	3.88M	-183K	-63K	-32K	924.57K
Other Non-Cash Items	21.78M	14.57M	-24.09M	8.74M	3.64M	-2.55M
Deferred Income Tax	-44K	-3.09M	-4.34M	-119K	-2.49M	n/a
Change in Working Capital	n/a	6.17M	-5.52M	-7.18M	1.92M	2.94M
Operating Cash Flow	-28.94M	-50.92M	-14.43M	-32.58M	-11.03M	-18.76M
Capital Expenditures	-892K	-5.41M	-6.14M	-1.15M	-293K	-128.35K
Cash Acquisitions	n/a	n/a	387.76K	-11.77M	252.89K	2.06M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5.41M	240.00	n/a	-252.89K	n/a
Investing Cash Flow	-892K	-5.41M	-5.75M	-12.91M	-293K	1.93M
Debt Repayment	n/a	n/a	-159K	n/a	41.24M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.16M	-163K	n/a	-5.27M	194K	n/a
Financial Cash Flow	2.16M	1.87M	325K	222.74M	41.44M	1.00
Net Cash Flow	-29.69M	-52.3M	-19.67M	170.79M	31.83M	-16.83M
Free Cash Flow	-29.83M	-56.34M	-20.57M	-33.73M	-11.32M	-18.89M